# Xenazine in Late Dyskinetic Syndrome With Neuroleptics

> **NCT01543321** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 54 (actual)

## Conditions studied

- Tardive Dyskinesia

## Interventions

- **DRUG:** Tetrabenazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01543321
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-14
- **Primary completion:** 2017-05-18
- **Final completion:** 2017-08
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01543321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01543321, "Xenazine in Late Dyskinetic Syndrome With Neuroleptics". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01543321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*